Sharon D Sielschott, LPC | |
8025 Ne Barberry Dr, Adair Village, OR 97330-9593 | |
(541) 740-5894 | |
Not Available |
Full Name | Sharon D Sielschott |
---|---|
Gender | Female |
Speciality | Counselor - Professional |
Location | 8025 Ne Barberry Dr, Adair Village, Oregon |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1760957583 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101YM0800X | Counselor - Mental Health | R4582 (Oregon) | Secondary |
101YP2500X | Counselor - Professional | C5148 (Oregon) | Primary |
Mailing Address | Practice Location Address |
---|---|
Sharon D Sielschott, LPC 8025 Ne Barberry Dr, Adair Village, OR 97330-9593 Ph: (541) 740-5894 | Sharon D Sielschott, LPC 8025 Ne Barberry Dr, Adair Village, OR 97330-9593 Ph: (541) 740-5894 |
News Archive
Water is essential when exercising in the heat but it might not be enough to keep you healthy in Houston summers.
Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Simvastatin Tablets USP, 5 mg, 10 mg, 20 mg, 40 mg and 80 mg, the generic version of Merck & Co.'s Zocor Tablets, a treatment for high cholesterol. The product will be distributed by Mylan Pharmaceuticals Inc.
Significant new research from Warwick Business School and Queen Mary, University of London, warns that delays and variability in the approvals process for clinical research could be causing pharmaceutical companies to look outside the UK and risks the country losing some of its most experienced researchers.
EyeLock Inc., a market leader of iris-based identity authentication solutions, today announced that it has been named a 2015 CES Innovation Awards Honoree for myris. Products entered in this prestigious program are judged by a preeminent panel of independent industrial designers, independent engineers and members of the trade media to honor outstanding design and engineering in cutting edge consumer electronics products across 28 product categories.
A team of researchers from various institutes across Pakistan, Chile, Canada, and the USA recently conducted a clinical trial to investigate the potential effectiveness of a combination of honey and Nigella sativa (HNS) in treating COVID-19 patients. Their study is published on the preprint server medRxiv prior to the scientific peer review process.
› Verified 9 days ago